The Global Spirometer Market size is expected to reach $1. 7 billion by 2026, rising at a market growth of 10. 2% CAGR during the forecast period. A spirometer refers to a medical device, used for estimating the accurate lungs’ functioning.New York, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Spirometer Market By End-use, By Application, By Product Type, By Technology, By Region, Industry Analysis and Forecast, 2020 - 2026" - https://www.reportlinker.com/p06021508/?utm_source=GNW The inhaled and exhaled volume of air from the lungs is calculated after the maximum inhalation by the patient. Spirometer assists in the diagnosis of various respiratory diseases, such as bronchitis and chronic lung diseases like emphysema, asthma, and other breathing diseases for monitoring in an occupational environment. Commonly, a spirometer is used to examine the function of the lungs before surgery in order to predict the type of respiratory diseases.The rate of chronic respiratory diseases has been increasing among adults and children across the world. The regulations regarding the diagnosis and treatment of asthma in children and the Global Initiative on Asthma (GINA) guidelines suggests the utilization of spirometry regularly for asthma. GINA launched a 2020 update for Global Strategy for Asthma Management and Prevention that includes information regarding asthma after evaluating the scientific literature and has citations from the scientific literature.Some of the factors such as surge in the rate of chronic respiratory diseases, advancements in technology, and rising inclinations for home-based healthcare are boosting the market growth. Organizations are developing advanced spirometers with enhanced features and design. The purpose behind is to streamline complicated procedure included in pulmonary function testing for patients and professionals. The primary aim is to develop spirometers that have a superior yield and enhanced patient comfort without complications. To prevent any kind of bacterial infection, organizations are implementing innovative packaging methods. Such developments in technology make testing methods simpler and convenient for patients.By End UseBased on End-use, the market is segmented into Hospitals & Clinics and Home Healthcare. The hospitals and clinics segment garnered the largest market share in 2019. This is because spirometry is widely performed in hospitals and clinics for the diagnosis and monitoring of chronic respiratory diseases. However, the home healthcare segment in Spirometer market is anticipated to register the highest growth rate over the forecast period.By ApplicationBased on Application, the market is segmented into COPD, Pulmonary Fibrosis, Asthma, Cystic Fibrosis and Others. The spirometer market was dominated by the COPD segment in 2019. This is owing to the high number of individuals who have mild to severe COPD. However, the asthma segment is anticipated to register the highest development over the forecast period.By Product TypeBased on Product Type, the market is segmented into Table Top, Desktop and Hand Held. The spirometer market was dominated by the tabletop segment and held the biggest market share in 2019. The growth of the market is defined by wide use in the diagnosis of obstructive airway disorders including asthma and other pulmonary diseases.By TechnologyBased on Technology, the market is segmented into Flow Measurement, Volume Measurement and Peak Flow Measurement. The peak flow measurement segment is anticipated to register the highest growth over the forecast period. Peak flow measurement devices are capable of providing alerts before an asthma attack by showing the contraction of lung airways. Therefore, medical care can be offered on time for patients with asthma.By RegionBased on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America was the leading segment of the Global Spirometers market in 2019. This is owing to the high rate of Chronic Obstructive Pulmonary Diseases (COPD) in the U.S. The Asia Pacific is anticipated to register the highest growth rate over the forecast period, owing to the increasing initiatives with respect to primary care for timely diagnosis and management of chronic lung diseases like COPD and asthma.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hill-Rom Holdings, Inc., Smiths Group PLC (Smiths Medical, Inc.), Koninklijke Philips N.V., Medline Industries, Inc., Schiller AG, Vyaire Medical, Inc., SDI Diagnostics, Inc., Nihon Kohden Corporation, Koko LLC and Fukuda Sangyo Co., Ltd.Strategies deployed in Spirometer Market2020-Nov: Royal Philips introduced a non-invasive ventilator, BiPAP A40 EFL. This ventilator remotely monitors patients with chronic obstructive pulmonary disease (COPD) and helps them to breathe easier.2020-Jun: KoKo LLC in collaboration with Belun Technology Company Ltd. launched the BLR-100C system for remote monitoring of COVID-19 patients. Belun’s Remote Monitoring Station tracks physiological parameters of multiple patients 24/7, freeing up essential resources and reducing the risk of medical and nursing home staff exposure to the virus.2020-May: Nihon Kohden unveiled the NK-HealthProtect Patient Triage Solution, a complete kit that includes tools necessary in evaluating patients potentially suffering from COVID-19. The major component of the kit is Nihon Kohden’s Life Scope SVM-7200 vital signs monitor that helps healthcare practitioners in quickly and easily measuring three vital signs key to COVID-19 screenings; temperature, blood oxygen and blood pressure.2019-Aug: Vyaire Medical got approval from U.S. Food and Drug Administration (FDA) for two of its latest Pulmonary Function Testing (PFT) technologies namely VyntusTM ONE, VyntusTM BODY with SentrySuiteTM Software. The Vyntus ONE is a convenient PFT station available in a fixed or mobile configuration that is patient-friendly and easy for clinicians to use. Vyntus BODY was designed for conducting body plethysmography. Both Vyntus ONE and Vyntus BODY consist of a newly designed Ultrasonic Flow Sensor that represents significant improvements in efficiency and accuracy of pulmonary function testing.2018-Nov: Schiller AG is launching five new products. These products include the medilogAR, the ECG device CARDIOVIT CS-104, the ErgoSpiro solution CARDIOVIT CS-200 Office ErgoSpiro, and two defibrillators— FRED easyport plus and FRED PA-1 Online.Scope of the StudyMarket Segments covered in the Report:By End Use• Hospitals & Clinics• Home HealthcareBy Application• COPD• Pulmonary Fibrosis• Asthma• Cystic Fibrosis• OthersBy Product Type• Table Top• Desktop• Hand HeldBy Technology• Flow Measurement• Volume Measurement• Peak Flow MeasurementBy Geography• North Americao USo Canadao Mexicoo Rest of North America• Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe• Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific• LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled• Hill-Rom Holdings, Inc.• Smiths Group PLC (Smiths Medical, Inc.)• Koninklijke Philips N.V.• Medline Industries, Inc.• Schiller AG• Vyaire Medical, Inc.• SDI Diagnostics, Inc.• Nihon Kohden Corporation• Koko LLC• Fukuda Sangyo Co., Ltd.Unique Offerings • Exhaustive coverage• Highest number of market tables and figures• Subscription based model available• Guaranteed best price• Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p06021508/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare:
[email protected] US: (339)-368-6001 Intl: +1 339-368-6001